Organisation
Hematology
Current researchers
1 - 10 of 18 results
- Fatema Afennas (Member)
- Veerle Beckers (Member)
- Charlotte Caron (Member)
- Ludwine Antoinette Claeys (Member)
- Ann De Becker (Member)
- Nathan De Beule (Member)
- Inke De Haes (Member)
- Sylvia Faict (Member)
- Karel Fostier (Member)
- Kristin Jochmans (Member)
Projects
1 - 1 of 1
- Tumor characterization and disease follow-up in multiple myeloma by (epi) genetic profiling using liquid biopsiesFrom1 Nov 2021 → TodayFunding: FWO junior postdoctoral fellowship
Publications
11 - 20 of 79
- Auto-immune hemolytic anemia and hemophagocytic lymphohistiocytosis as immune-related adverse event in patients with metastatic melanoma and concurrent chronic lymphocytic leukemia(2023)
Authors: Iris Dirven, An-Sofie Vander Mijnsbrugge, Sacha Mignon, Jens Tijtgat, Nicolas Kint, Bart Neyns
Pages: 338-344 - Switching to daratumumab SC from IV is safe and preferred by patients with multiple myeloma(2023)
Authors: Maria-Victoria Mateos, Sophie Rigaudeau, Supratik Basu, Ivan Spicka, Rik Schots, Tomasz Wrobel, Gordon Cook, Meral Beksac, Katharine S Gries, Anupa Kudva, et al.
Pages: 1172-1177 - Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics(2020)
Authors: Inke De Haes, Amélie Dendooven, Marie Le Mercier, Pauline Puylaert, Katrien Vermeulen, Mark Kockx, Kathleen Deiteren, Marie Maes, Zwi Berneman, Sébastien Anguille
Pages: 1-12 - Allogeneic hematopoietic cell transplantation in patients with chronic phase chronic myeloid leukemia in the era of third generation tyrosine kinase inhibitors(2023)
Authors: Yves Chalandon, Giulia Sbianchi, Luuk Gras, Linda Koster, Jane F. Apperley, Jenny L. Byrne, Urpu Salmenniemi, Henrik Sengeloev, Mahmoud Aljurf, Grzegorz Helbig, et al.
Pages: 112-121 - Heterozygosity for bisphosphoglycerate mutase deficiency expressing clinically as congenital erythrocytosis(2023)
Authors: Myrthe J van Dijk, Brigitte A van Oirschot, Manon C Stam-Slob, Esmé Waanders, Bert van der Zwaag, Eduard J van Beers, Judith J M Jans, Peter Willem van der Linden, Jose M Torregrosa Diaz, Betty Gardie, et al.
Pages: 249-255 - Impact of lenalidomide maintenance on the immune environment of multiple myeloma patients with low tumor burden after autologous stem cell transplantation(2018)
Authors: Karel Fostier, Jo Caers, Nathalie Meuleman, Jurgen Corthals, Brenda De Keersmaecker
Pages: 20476-20489 - Combination therapy for a durable tumor rejection(2018)
Authors: Lukasz Bialkowski, Kris Thielemans, Joeri L Aerts
- The prognostic value and therapeutic targeting of myeloid-derived suppressor cells in hematological cancers(2022)
Authors: Rong Fan, Nathan De Beule, Anke Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Ken Maes, K Breckpot, Kim De Veirman
- AXL Receptor Tyrosine Kinase as a Therapeutic Target in Hematological Malignancies(2019)
Authors: Siyang Yan, Niels Vandewalle, Nathan De Beule, Sylvia Faict, Ken Maes, Elke De Bruyne, Eline Menu, Karin Vanderkerken, Kim De Veirman
Pages: 1-17 - Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation(2018)
Authors: Willem Staels, Yannick Verdonck, Yves Heremans, Gunter Leuckx, Sofie De Groef, Carlo Heirman, Eelco De Koning, Conny Gysemans, Kris Thielemans, L Baeyens, et al.
Pages: 1804-1810